Remote Delivery of Allied Health Therapies in Parkinson’s Disease
Journal of Parkinson’s Disease · 2024
DOI: 10.3233/jpd-230214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Parkinson’s Disease, 2024. Verfasst von Ryan P Duncan und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Program in Physical Therapy, Washington University in St. Louis, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Parkinson Disease, COVID-19, Telemedicine, Occupational Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Remote delivery of allied health therapies has long been possible, but adoption has been limited in some disciplines until relatively recently. The COVID-19 pandemic drove dramatic increases in use of remote delivery within allied health. This review summarizes the latest evidence on remotely-delivered physical therapy, occupational therapy, and speech therapy and discusses associated challenges and opportunities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Program in Physical Therapy, Washington University in St. Louis, St. Louis, MO, USA.
- Department of Neurology, School of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
- Department of Neuroscience, Washington University in St. Louis, St. Louis, MO, USA.
Förderung
- NICHD NIH HHS
Zitieren
APA
Duncan, R. P., & Earhart, G. M. (2024). Remote Delivery of Allied Health Therapies in Parkinson’s Disease. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-230214
Vancouver
Duncan RP, Earhart GM. Remote Delivery of Allied Health Therapies in Parkinson’s Disease. Journal of Parkinson’s Disease. 2024. doi:10.3233/jpd-230214
BibTeX
@article{Duncan2024,
author = {Duncan, Ryan P and Earhart, Gammon M},
title = {Remote Delivery of Allied Health Therapies in Parkinson’s Disease},
journal = {Journal of Parkinson’s Disease},
year = {2024},
doi = {10.3233/jpd-230214}
}
EUVIMED